Chemotherapy in biliary tract cancer
G Tonini1, M E Frato, B Vincenzi
1Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy. g.tonini@unicampus.it
Summary
Biliary tract cancer is aggressive and often resistant to standard treatments. This review covers clinical trials on chemotherapy, adjuvant therapies, and targeted treatments like anti-EGFR agents for better patient outcomes.
Area of Science:
- Oncology
- Gastroenterology
- Clinical Trials
Background:
- Biliary tract cancer (BTC) is a rare, aggressive malignancy with poor response to chemotherapy and radiotherapy.
- Surgical resection offers the only curative option, but high rates of post-operative recurrence remain a significant challenge.
- Limited randomized trials exist, and no standard chemotherapy regimen is established for BTC.
Purpose of the Study:
- To review pivotal clinical trials in biliary tract cancer chemotherapy.
- To discuss emerging evidence on adjuvant treatment strategies.
- To summarize trials evaluating targeted therapies, including anti-EGFR and antiangiogenic agents.
Main Methods:
- Systematic review of published clinical trials.
- Analysis of data from randomized controlled trials and observational studies.
- Evaluation of targeted therapy agents in biliary tract cancer.
Main Results:
- Chemotherapy and radiotherapy show limited efficacy in most BTC cases.
- Adjuvant treatment strategies are under investigation to improve outcomes.
- Targeted therapies, particularly anti-EGFR and antiangiogenic agents, show promise in clinical trials.
Conclusions:
- Chemotherapy remains a challenge in biliary tract cancer management.
- Adjuvant and targeted therapies represent promising avenues for improving BTC treatment.
- Further research is needed to establish optimal treatment protocols.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...